Literature DB >> 35267010

Hyperinflammatory Syndrome, Natural Killer Cell Function, and Genetic Polymorphisms in the Pathogenesis of Severe Dengue.

Nguyen Lam Vuong1,2, Ka Wai Cheung3, Balamurugan Periaswamy4, Tran Thuy Vi1, Huynh Thi Le Duyen1, Yan Shan Leong3, Zayanah Noor Binte Hamis3, Michaela Gregorova5, Eng Eong Ooi3,6, October Sessions3,6,7, Laura Rivino3,5, Sophie Yacoub1,8.   

Abstract

BACKGROUND: Severe dengue, characterized by shock and organ dysfunction, is driven by an excessive host immune response. We investigated the role of hyperinflammation in dengue pathogenesis.
METHODS: Patients recruited into an observational study were divided into 3 plasma leak severity grades. Hyperinflammatory biomarkers were measured at 4 time points. Frequencies, activation, and cytotoxic potential of natural killer (NK) cells were analyzed by flow cytometry. RNA was extracted from sorted CD56+ NK cells and libraries were prepared using SMART-Seq and sequenced using HiSeq3000 (Illumina).
RESULTS: Sixty-nine patients were included (grade 0, 42 patients; grade 1, 19 patients; grade 2, 8 patients). Patients with grade 2 leakage had higher biomarkers than grade 0, including higher peak ferritin levels (83.3% vs 45.2%) and H-scores (median, 148.5 vs 105.5). NK cells from grade 2 patients exhibited decreased expression of perforin and granzyme B and activation markers. RNA sequencing revealed 3 single-nucleotide polymorphisms in NK cell functional genes associated with more severe leakage-NK cell lectin-like receptor K1 gene (KLRK1) and perforin 1 (PRF1).
CONCLUSIONS: Features of hyperinflammation are associated with dengue severity, including higher biomarkers, impaired NK cell function, and polymorphisms in NK cell cytolytic function genes (KLRK1 and PRF1). Trials of immunomodulatory therapy in these patients is now warranted.
© The Author(s) 2022. Published by Oxford University Press for the Infectious Diseases Society of America.

Entities:  

Keywords:  dengue; hyperinflammation; immunomodulation; macrophage activation syndrome; single-nucleotide polymorphisms

Mesh:

Substances:

Year:  2022        PMID: 35267010      PMCID: PMC9574659          DOI: 10.1093/infdis/jiac093

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   7.759


  35 in total

Review 1.  Immune evasion of natural killer cells by viruses.

Authors:  Stipan Jonjić; Marina Babić; Bojan Polić; Astrid Krmpotić
Journal:  Curr Opin Immunol       Date:  2008-02       Impact factor: 7.486

Review 2.  Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies.

Authors:  Grant S Schulert; Alexei A Grom
Journal:  Annu Rev Med       Date:  2014-11-05       Impact factor: 13.739

Review 3.  Macrophage activation syndrome in adults: recent advances in pathophysiology, diagnosis and treatment.

Authors:  Stuart J Carter; Rachel S Tattersall; Athimalaipet V Ramanan
Journal:  Rheumatology (Oxford)       Date:  2019-01-01       Impact factor: 7.580

4.  Higher Plasma Viremia in the Febrile Phase Is Associated With Adverse Dengue Outcomes Irrespective of Infecting Serotype or Host Immune Status: An Analysis of 5642 Vietnamese Cases.

Authors:  Nguyen Lam Vuong; Nguyen Than Ha Quyen; Nguyen Thi Hanh Tien; Nguyen Minh Tuan; Duong Thi Hue Kien; Phung Khanh Lam; Dong Thi Hoai Tam; Tran Van Ngoc; Sophie Yacoub; Thomas Jaenisch; Ronald B Geskus; Cameron P Simmons; Bridget A Wills
Journal:  Clin Infect Dis       Date:  2021-06-15       Impact factor: 9.079

5.  Hyperferritinaemia in dengue virus infected patients is associated with immune activation and coagulation disturbances.

Authors:  Cornelia A M van de Weg; Ralph M H G Huits; Cláudio S Pannuti; Rosalba M Brouns; Riemsdijk W A van den Berg; Henk-Jan van den Ham; Byron E E Martina; Albert D M E Osterhaus; Mihai G Netea; Joost C M Meijers; Eric C M van Gorp; Esper G Kallas
Journal:  PLoS Negl Trop Dis       Date:  2014-10-09

Review 6.  Recent advances in understanding dengue.

Authors:  Sophie Yacoub; Juthathip Mongkolsapaya; Gavin Screaton
Journal:  F1000Res       Date:  2016-01-19

Review 7.  NKG2D: A Master Regulator of Immune Cell Responsiveness.

Authors:  Felix M Wensveen; Vedrana Jelenčić; Bojan Polić
Journal:  Front Immunol       Date:  2018-03-08       Impact factor: 7.561

8.  Targeting hyperinflammation in infection: can we harness the COVID-19 therapeutics momentum to end the dengue drugs drought?

Authors:  Angela McBride; Puja Mehta; Laura Rivino; Athimalaipet V Ramanan; Sophie Yacoub
Journal:  Lancet Microbe       Date:  2021-04-20

9.  COVID-19: consider cytokine storm syndromes and immunosuppression.

Authors:  Puja Mehta; Daniel F McAuley; Michael Brown; Emilie Sanchez; Rachel S Tattersall; Jessica J Manson
Journal:  Lancet       Date:  2020-03-16       Impact factor: 79.321

Review 10.  New insights into the immunopathology and control of dengue virus infection.

Authors:  Gavin Screaton; Juthathip Mongkolsapaya; Sophie Yacoub; Catherine Roberts
Journal:  Nat Rev Immunol       Date:  2015-12       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.